nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.1	0.1	CbGpPWpGaD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.088	0.088	CbGpPWpGaD
Levomilnacipran—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.073	0.073	CbGpPWpGaD
Levomilnacipran—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0641	0.0641	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—CNDP2—pharynx cancer	0.059	0.059	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—ADH7—pharynx cancer	0.0533	0.0533	CbGpPWpGaD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0478	0.0478	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—ADH1B—pharynx cancer	0.0467	0.0467	CbGpPWpGaD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0419	0.0419	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—ADH7—pharynx cancer	0.0349	0.0349	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—ADH7—pharynx cancer	0.03	0.03	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0251	0.0251	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0224	0.0224	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.022	0.022	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0206	0.0206	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0196	0.0196	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.018	0.018	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.0147	0.0147	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0134	0.0134	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.0133	0.0133	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.0131	0.0131	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.0121	0.0121	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.0119	0.0119	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0118	0.0118	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.0117	0.0117	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.0109	0.0109	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.0104	0.0104	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CNDP2—pharynx cancer	0.0101	0.0101	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00958	0.00958	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH7—pharynx cancer	0.00912	0.00912	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH1B—pharynx cancer	0.00799	0.00799	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.0079	0.0079	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—B4GALT5—pharynx cancer	0.00764	0.00764	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00714	0.00714	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00626	0.00626	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TP53—pharynx cancer	0.00339	0.00339	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.00252	0.00252	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH7—pharynx cancer	0.00228	0.00228	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.00225	0.00225	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CNDP2—pharynx cancer	0.00219	0.00219	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.00207	0.00207	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00203	0.00203	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH7—pharynx cancer	0.00203	0.00203	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.002	0.002	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH7—pharynx cancer	0.00198	0.00198	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.00191	0.00191	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH7—pharynx cancer	0.00187	0.00187	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.00178	0.00178	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH1B—pharynx cancer	0.00174	0.00174	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.0017	0.0017	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.00166	0.00166	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.00164	0.00164	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00159	0.00159	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.00157	0.00157	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.00135	0.00135	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00134	0.00134	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH7—pharynx cancer	0.00122	0.00122	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.00107	0.00107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.00102	0.00102	CbGpPWpGaD
